Definitive Contract 75N91019C00048
Award Date 9/16/19
Potential Completion Date 10/31/20
Potential Value $300K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Wellesley, MA 02482, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This is a $1,999,961.00 Firm Fixed Price contract awarded by the National Cancer Institute (NCI) to Kephera Diagnostics LLC, a for-profit limited liability company. The contract was set aside for small businesses under the Small Business Innovation Research (SBIR) program. The contract is for the development of an in vitro diagnostic test for the liver flukes Opisthorchis viverrini and Clonorchis sinensis, with a period of performance through March 15, 2026. Kephera Diagnostics specializes in...
- This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Kephera Diagnostics LLC, a for-profit limited liability company. The contract is part of the SBIR 133 program, which does not have a set-aside designation. The contract focuses on advancing Kephera Diagnostics' research and development of innovative diagnostic solutions for infectious diseases, with a particular emphasis on neglected tropical...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Crosslife Technologies Inc., a for-profit small business, for $299,987.00. The contract is for the development of a point of care nucleic acids test for the detection of the liver flukes Opisthorchis viverrini and Clonorchis. This contract is a Definitive Contract with a Firm Fixed Price pricing type. The...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract for $299,991.00 to Qoolabs Inc., a self-certified small disadvantaged business. The contract is for the development of point-of-care diagnostics for the detection of the liver flukes Opisthorchis viverrini and Clonorchis sinensis, under Topic 388. The work will be performed by Qoolabs Inc. in San Diego, California. Qoolabs Inc....
- This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Kephera Diagnostics LLC, a small business, for the discovery and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is a Small Business Innovation Research (SBIR) Phase I award, meaning it supports early-stage research and development efforts. The work will be performed in Framingham,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase I contract to Kephera Diagnostics LLC, a for-profit limited liability company, to develop a biomarker-based test of cure (TOC) to evaluate treatment outcome during the chronic phase of Chagas infection. The contract, a Definitive Contract with Firm Fixed Price pricing, has a potential value of $300,000.00 and a...
- This is a Small Business Innovation Research (SBIR) Phase 1 contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Kephera Diagnostics LLC, a small business. The contract is for the development of diagnostics to detect taeniasis, a parasitic infection, in order to prevent neurocysticercosis and associated epilepsy. The award amount is $150,000.00 and the contract has a firm fixed price pricing type. The contract was set aside...
- This is a $300,000.00 firm fixed price contract awarded by the National Institutes of Health (NIH), part of the Department of Health and Human Services, to Nanohmics Inc., a small business, under the Small Business Innovation Research (SBIR) program. The contract is for the development of DNA aptamer-based lateral flow assays for detecting liver flukes in Phase I of the SBIR program. The contract has a completion date of December 15, 2021 and was awarded on September 16, 2019. Nanohmics Inc....
- This is a $273,600 firm-fixed-price definitive contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to JBS Science Inc., a small business biotechnology company. The contract is for the development of a cell-free circulating DNA-based assay for liver cancer screening. This award supports NCI's efforts to advance innovative molecular diagnostic technologies for cancer detection and monitoring. As a small business set-aside contract, the...
- This $400,000 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Amplifidx Inc., a woman-owned small business. The contract supports the development of cancer prevention and diagnosis technologies for low-resource settings over a two-year period. This award aligns with NCI's mission to support innovative medical device research and development by small businesses. As a SBIR...